Cargando…
Hypoglycemic agents and potential anti-inflammatory activity
Current literature shows an association of diabetes and secondary complications with chronic inflammation. Evidence of these immunological changes include altered levels of cytokines and chemokines, changes in the numbers and activation states of various leukocyte populations, apoptosis, and fibrosi...
Autores principales: | Kothari, Vishal, Galdo, John A, Mathews, Suresh T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833364/ https://www.ncbi.nlm.nih.gov/pubmed/27114714 http://dx.doi.org/10.2147/JIR.S86917 |
Ejemplares similares
-
Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
por: Xu, Bilin, et al.
Publicado: (2022) -
Oral hypoglycemic agents: do the ends justify the means?
por: Langer, Oded
Publicado: (2015) -
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
por: Ge, Derek, et al.
Publicado: (2022) -
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis
por: Khayat, Maan T., et al.
Publicado: (2022) -
Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)